Market Place
Sourcing Support
Valeo Pharma Hits Record Q2 Revenue With Rising Asthma Product Demand
17 Jun 2024 //
ACCESSWIRE
Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru
14 Sep 2022 //
NEWSWIRE
Valeo Pharma Adds Kyle Steiger To Leadership Team
30 Aug 2022 //
PRESS RELEASE
Valeo Pharma enters agreement with Kaleo to produce epinephrine auto-injector
02 Aug 2022 //
PROACTIVEINVESTORS
Valeo Pharma Obtains Public Reimbursement For Enerzair & Atectura Breezhaler
24 Feb 2022 //
PRNEWSWIRE
Valeo Announces Upsize of Previously Announced Bought Deal Private Placement
24 Nov 2021 //
GLOBENEWSWIRE
Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec
15 Nov 2021 //
NEWSWIRE
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR BREEZHALERS IN ALBERTA
03 Nov 2021 //
PRESS RELEASE
Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare
13 Oct 2021 //
PRNEWSWIRE
Valeo Pharma Obtains Listings for Redesca from Two GPO
13 Oct 2021 //
PRNEWSWIRE
Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance
05 Oct 2021 //
PRNEWSWIRE
Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™
13 Jul 2021 //
PRNEWSWIRE
Valeo Pharma Launches Enerzair® Breezhaler® and Atectura® Breezhaler®
22 Jun 2021 //
PRNEWSWIRE
Valeo Pharma: Commercial Launch of Enerzair Breezhaler & Atectura Breezhaler
22 Jun 2021 //
PRNEWSWIRE
Valeo Pharma`s Redesca® and Redesca HP® to Be Covered Under the Ontario
28 Apr 2021 //
PRNEWSWIRE
Valeo Pharma Announces Commercial Launch of Redesca™ and Redesca HP™
16 Apr 2021 //
PRNEWSWIRE
Valeo Pharma Completes Negotiations with Pan-Canadian
06 Apr 2021 //
BIOSPACE
Valeo Pharma Inc. Enters into an Agreement for Enerzair & Breezhaler
29 Mar 2021 //
BIOSPACE
Valeo Pharma Enters into an Agreement for Enerzair® Breezhaler® and Atectura®
29 Mar 2021 //
PRNEWSWIRE
Valeo Hesperco™ Capsules at the Core of Montreal Heart Institute`s Hesperidin
17 Feb 2021 //
PRNEWSWIRE
Valeo Pharma’s Redesca receives positive review for public reimbursement
25 Jan 2021 //
PROACTIVENVESTOR
Valeo Pharma Announces Major Addition to its Senior Management Team
18 Jan 2021 //
PRNEWSWIRE
Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin
12 Jan 2021 //
PRNEWSWIRE
Valeo announces Amikacin approval in CANADA & U.S. launch of Ethacrynate Sodium
12 Nov 2020 //
PRNEWSWIRE
Valeo Pharma Begins Trading on the U.S. OTCQB Market
23 Sep 2020 //
PRNEWSWIRE
Valeo Pharma files natural product license with Health Canada for bioflavonoid
24 Aug 2020 //
PHARMABIZ
Valeo Pharma Announces $6.0 Million Bought Deal Financing
20 Aug 2020 //
NEWSWIRE
Valeo Pharma Commences Yondelis® Commercialization in Canada
12 Aug 2020 //
NEWSWIRE
Valeo Pharma Licenses Canadian Rights to Ametop™ Gel from Alliance Pharma
13 Jul 2020 //
NEWSWIRE
Valeo Pharma Closes $1.7 Million Oversubscribed Private Placement
11 Jul 2020 //
NEWSWIRE
Valeo Pharma`s Onstryv® Receives +ve Recommendation for Public Reimbursement
06 Feb 2020 //
NEWSWIRE
Zambon and Valeo Pharma launch PD drug Onstryv in Canada
11 Jul 2019 //
THE PHARMALETTER
Valeo Pharma & Zambon Form Partnership for Parkinson’s Disease Treatment Xadago
11 Apr 2017 //
BUSINESSWIRE
